Study tracks pneumococcal infections in adults to sharpen vaccine strategies

NCT ID NCT03983616

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study monitored 1560 adults hospitalized with invasive pneumococcal infections (excluding meningitis) across France. Researchers collected information on infection severity, risk factors, and bacterial serotypes to understand how these infections occur and how vaccines might be better targeted. The goal was to provide data that could guide future vaccination recommendations for adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this surveillance could help refine vaccine guidelines for adults against pneumococcal infections.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove that any vaccine works; it only gathers data to inform future recommendations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumococcal infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Virologie

    Limoges, France